Windlas Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

10.48

10.40

10.46

10.90

6.41

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

495.31

439.89

392.20

384.23

192.58

Loan funds

Secured loans

27.12

0.11

0.44

6.12

30.24

Unsecured loans

-

-

-

-

-

Total

532.91

450.40

403.11

401.25

229.23

Uses of funds

Fixed assets

Gross block

337.02

271.11

187.61

158.73

152.73

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

113.64

92.06

78.20

67.54

56.79

Net block

223.39

179.05

109.41

91.18

95.94

Capital work-in-progress

5.32

5.71

14.78

8.01

0.04

Investments

223.37

173.44

106.55

64.86

23.18

Net current assets

Current assets, loans & advances

308.37

267.97

298.28

326.97

176.84

Less : current liabilities & provisions

227.54

175.76

125.90

89.78

66.77

Total net current assets

80.83

92.21

172.38

237.19

110.07

Miscellaneous expenses not written

-

-

-

-

-

Total

532.91

450.40

403.11

401.25

229.23

Notes:

Book value of unquoted investments

-

-

0.03

64.86

0.03

Market value of quoted investments

223.37

173.44

106.51

-

23.14

Contingent liabilities

2.08

15.29

14.11

3.25

-

Number of equity sharesoutstanding (Lacs)

209.59

207.99

209.27

217.94

64.11